New Insights from LexisNexis Risk Solutions Highlight the Latest Trends for Breast and Colon Cancer Diagnoses and Screenings
LexisNexis Risk Solutions released new insights on breast and colon cancer screening trends from 2021-2023. Mammogram screenings increased significantly, with a 10.3% rise among people in their 40s and a 12.5% increase for those in their 30s. Breast cancer diagnoses showed notable increases, particularly among people in their 30s (4% increase) and over 70 (5.7% increase).
Following USPSTF's updated guidelines lowering the recommended age for colon cancer screenings to 45, colonoscopies in the 45-50 age group surged by 90%. While at-home screening tests generally decreased, their utilization among people in their 40s increased significantly, with DNA-based tests up 30.5% and FIT up 19.7%.
LexisNexis Risk Solutions ha rilasciato nuove informazioni sulle tendenze dei controlli per il cancro al seno e al colon dal 2021 al 2023. I controlli mammografici sono aumentati significativamente, con un incremento del 10,3% tra le persone nei loro 40 anni e del 12,5% per quelle nei loro 30 anni. Le diagnosi di cancro al seno hanno mostrato aumenti notevoli, in particolare tra le persone nei loro 30 anni (aumento del 4%) e tra quelle over 70 (aumento del 5,7%).
In seguito all'aggiornamento delle linee guida USPSTF che ha abbassato l'età raccomandata per i controlli del cancro al colon a 45 anni, le colonoscopie nel gruppo di età 45-50 anni sono aumentate del 90%. Sebbene i test di screening a domicilio siano generalmente diminuiti, il loro utilizzo tra le persone nei loro 40 anni è aumentato significativamente, con i test basati su DNA in crescita del 30,5% e i test FIT in aumento del 19,7%.
LexisNexis Risk Solutions publicó nuevos datos sobre las tendencias de detección de cáncer de mama y colon de 2021 a 2023. Las pruebas de mamografía aumentaron significativamente, con un incremento del 10.3% entre las personas de 40 años y un aumento del 12.5% para aquellos en sus 30 años. Los diagnósticos de cáncer de mama mostraron aumentos notables, especialmente entre las personas en sus 30 años (aumento del 4%) y mayores de 70 años (aumento del 5.7%).
Tras las nuevas recomendaciones de USPSTF que redujeron la edad recomendada para la detección de cáncer de colon a 45 años, las colonoscopias en el grupo de edad de 45 a 50 años se dispararon en un 90%. Si bien las pruebas de detección en casa generalmente disminuyeron, su uso entre personas de 40 años aumentó significativamente, con pruebas basadas en ADN que crecieron un 30.5% y pruebas FIT que aumentaron un 19.7%.
LexisNexis 리스크 솔루션즈는 2021년부터 2023년까지 유방암 및 대장암 검사 경향에 대한 새로운 통찰력을 발표했습니다. 유방촬영 검사는 40대에서 10.3% 증가하고 30대에서 12.5% 증가하는 등 크게 증가했습니다. 유방암 진단도 특히 30대에서 4% 증가하고 70세 이상에서 5.7% 증가하여 주목할 만한 상승을 보였습니다.
USPSTF의 권고에 따라 대장암 검사의 권장 연령이 45세로 낮춰진 후, 대장내시경 검사는 45-50세 그룹에서 90% 급증했습니다. 자가 검사 키트 사용은 일반적으로 감소했지만, 40대에서의 활용도는 크게 증가하여 DNA 기반 검사는 30.5% 증가하고 FIT 검사는 19.7% 증가했습니다.
LexisNexis Risk Solutions a publié de nouvelles informations sur les tendances de dépistage du cancer du sein et du côlon de 2021 à 2023. Les dépistages mammographiques ont augmenté de manière significative, avec une hausse de 10,3 % parmi les personnes dans la trentaine et de 12,5 % parmi celles dans la quarantaine. Les diagnostics de cancer du sein ont montré des augmentations notables, en particulier chez les personnes dans leur trentaine (augmentation de 4 %) et chez les plus de 70 ans (augmentation de 5,7 %).
A la suite des nouvelles recommandations de l'USPSTF abaissant l'âge recommandé pour le dépistage du cancer du côlon à 45 ans, les coloscopies dans le groupe d'âge de 45 à 50 ans ont explosé de 90 %. Bien que l'utilisation des tests de dépistage à domicile ait généralement diminué, leur utilisation parmi les personnes dans la quarantaine a considérablement augmenté, les tests basés sur l'ADN augmentant de 30,5 % et les tests FIT de 19,7 %.
LexisNexis Risk Solutions hat neue Erkenntnisse zu den Trends bei Brust- und Dickdarmkrebsvorsorgeuntersuchungen von 2021 bis 2023 veröffentlicht. Die Mammographie-Screenings stiegen erheblich an, mit einem Anstieg von 10,3% bei Personen in ihren 40ern und einem Anstieg von 12,5% bei Personen in ihren 30ern. Die Diagnosen von Brustkrebs zeigten bemerkenswerte Zuwächse, insbesondere bei Personen in ihren 30ern (Anstieg von 4%) und über 70 (Anstieg von 5,7%).
Nach den aktualisierten Richtlinien der USPSTF, die das empfohlene Alter für Dickdarmkrebsvorsorgeuntersuchungen auf 45 Jahre senkten, stieg die Zahl der Darmspiegelungen in der Altersgruppe von 45 bis 50 Jahren um 90%. Während die Nutzung von Selbsttestkits insgesamt zurückging, stieg deren Anwendung bei Personen in ihren 40ern erheblich an, wobei DNA-basierte Tests um 30,5% und FIT-Tests um 19,7% zunahmen.
- Significant increase in mammogram screenings across younger age groups
- 90% increase in colonoscopies for 45-50 age group following new guidelines
- 30.5% increase in DNA-based tests and 19.7% increase in FIT tests among people in their 40s
- Overall decline in at-home, non-invasive colon cancer screening tests
- 5.7% increase in breast cancer diagnoses among people over 70, representing over 100,000 additional cases
Insights
This data analysis from LexisNexis Risk Solutions reveals significant market shifts in cancer screening trends that could impact healthcare service providers and medical technology companies. The
The breast cancer screening data shows notable market expansion, with
Findings show which age groups are seeing the biggest increases
Even though the USPSTF didn't officially lower the age recommendation for breast cancer screenings from 50 to 40 until April 2024, mammograms among adults in their 40s have been trending up for the last three years. De-identified medical claims data from LexisNexis® MarketView™ show a
The data analysis also revealed an increase in breast cancer diagnoses with the largest increases being among people in their 30s and people over 70. Breast cancer diagnoses among people in their 30s increased by
USPSTF lowered the recommend age for colon cancer screenings from 50 to 45 in May 2021, and the data shows this new age group is responding to the updated guidance. Colonoscopies among people between 45 and 50 years old increased
Additionally, the analysis examined the latest utilization trends of at-home, non-invasive colon cancer screening tests, including stool DNA-based tests and a fecal immunochemical test (FIT). Overall, these tests are trending down, indicating a potential pullback from high pandemic-driven utilization. However, utilization among people in their 40s is up
"These insights demonstrate the importance of timely and consistent population health monitoring. Using up-to-date claims data empowers healthcare organizations to examine policy change, healthcare delivery trends, and more effectively design programs that improve engagement and participation in preventive care, such as cancer screenings," said Diana Zuskov, associate vice president of healthcare strategy and innovation at LexisNexis Risk Solutions. "New innovations, such as non-invasive direct to consumer testing, show promise in improving the patient experience while also expanding reach and access to preventive care. Timely data on how patients are impacted by changing guidelines and healthcare innovation is critical to removing barriers to care and addressing health disparities among groups with limited access to care."
Click here to view the complete data analysis.
About LexisNexis Risk Solutions
LexisNexis Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, healthcare and government. Headquartered in metro
Media Contact:
Syed Shabbir
Sr. Manager, Corporate Communications
LexisNexis Risk Solutions
816-572-7709
syed.shabbir@lexisnexisrisk.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-insights-from-lexisnexis-risk-solutions-highlight-the-latest-trends-for-breast-and-colon-cancer-diagnoses-and-screenings-302290541.html
SOURCE LexisNexis Risk Solutions
FAQ
What was the increase in mammogram screenings for people in their 40s from 2021 to 2023?
How much did colonoscopies increase for ages 45-50 after the new USPSTF guidelines?
What was the increase in breast cancer diagnoses for people in their 30s?
How did at-home colon cancer screening test usage change for people in their 40s?
